Clinical Trials Update: June 12, 2006
Heartburn Solid Tumors Diabetes - Type 1
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study is evaluating an investigational medication to treat frequent heartburn. To pre-qualify, you must be 18 or older and must have had heartburn at least two days per week over the past month. Participants will receive a study-related medical evaluation and the investigational medication at no cost. Reimbursement for travel will be provided.
The research site is in Richmond, Va.
This study will investigate a new anti-cancer drug called AMT. Volunteers who have cancer confirmed by histology or cytology, at least one measurable lesion, advanced disease refractory to standard therapy or for which no standard therapy exists, and life expectancy of at least three months may qualify.
The research site is in Baden Wuerttemberg, Germany.
Diabetes - Type 1
People between ages 18 and 60 with type 1 diabetes mellitus are needed for a research study of an investigational monoclonal antibody. Candidates must be generally in good health with a history of type 1 diabetes mellitus, must be willing to stay in the clinic overnight, and must have been on a stable dose of any existing medications for four weeks. Multiple blood draws will be required.
The research site is in Lenexa, Kan.
Copyright 2006 Thomson CenterWatch. All rights reserved.